1921
Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Yellow fever virus is a global health threat due to its endemicity in parts of Africa and South America where human infections occur in residents and travelers. To understand yellow fever dynamics, it is critical to characterize the incubation periods of the virus in vector mosquitoes and humans. Here, we compare four statistical models of the yellow fever incubation periods fitted with historical data. The extrinsic incubation period in the urban vector was best characterized with a temperature-dependent Weibull model with a median of 10 days at 25°C (middle 95% = 2.0–37 days). The intrinsic incubation period, fitted with a log-normal model, had a median of 4.3 days (middle 95% = 2.3–8.6 days). These estimates and their associated statistical models provide a quantitative basis to assist in exposure assessments, model potential outbreaks, and evaluate the effectiveness of public health interventions.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2010.09-0782
2010-07-06
2019-05-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/83/1/183.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0782&mimeType=html&fmt=ahah

References

  1. Monath TP, , 2001. Yellow fever: an update. Lancet Infect Dis 1: 1120.[Crossref] [Google Scholar]
  2. Staples JE, Monath TP, , 2008. Yellow fever: 100 years of discovery. J Am Med Assoc 300: 960962.[Crossref] [Google Scholar]
  3. Vainio J, Cutts F, , 1998. Yellow Fever. Geneva: World Health Organization. [Google Scholar]
  4. Pan American Health Organization, 2008. Outbreak of yellow fever in Paraguay. Epidemiol Bull 27: 2. [Google Scholar]
  5. Theiler M, Smith H, , 1937. The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65: 787800.[Crossref] [Google Scholar]
  6. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K, , 1996. Yellow fever: a decade of reemergence. J Am Med Assoc 276: 11571162.[Crossref] [Google Scholar]
  7. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, , 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 60776082.[Crossref] [Google Scholar]
  8. World Health Organization Department of Immunization Vaccines and Biologicals, 2009. Vaccine Preventable Diseases: Monitoring System. Available at: http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidenceyfe.htm. Accessed November 4, 2009. [Google Scholar]
  9. World Health Organization Division of Epidemiological Surveillance and Health Situation Trend Assessment, 1992. Global Health Situation and Projections—Estimates. Geneva: World Health Organization. [Google Scholar]
  10. World Health Organization, 1996. The State of World Health: World Health Report. Geneva: World Health Organization. [Google Scholar]
  11. Barros ML, Boecken G, , 1996. Jungle yellow fever in the central Amazon. Lancet 348: 969970.[Crossref] [Google Scholar]
  12. McFarland JM, Baddour LM, Nelson JE, Elkins SK, Craven RB, Cropp BC, Chang GJ, Grindstaff AD, Craig AS, Smith RJ, , 1997. Imported yellow fever in a United States citizen. Clin Infect Dis 25: 11431147.[Crossref] [Google Scholar]
  13. Teichmann D, Grobusch MP, Wesselmann H, Temmesfeld-Wollbruck B, Breuer T, Dietel M, Emmerich P, Schmitz H, Suttorp N, , 1999. A haemorrhagic fever from the Cote d'Ivoire. Lancet 354: 1608.[Crossref] [Google Scholar]
  14. Centers for Disease Control and Prevention, 2000. Fatal yellow fever in a traveler returning from Venezuela, 1999. MMWR Morb Mortal Wkly Rep 49: 303305. [Google Scholar]
  15. Colebunders R, Mariage JL, Coche JC, Pirenne B, Kempinaire S, Hantson P, Van Gompel A, Niedrig M, Van Esbroeck M, Bailey R, Drosten C, Schmitz H, , 2002. A Belgian traveler who acquired yellow fever in The Gambia. Clin Infect Dis 35: e113e116.[Crossref] [Google Scholar]
  16. Centers for Disease Control and Prevention, 2002. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. MMWR Morb Mortal Wkly Rep 51: 324325. [Google Scholar]
  17. Struchiner CJ, Luz PM, Dourado I, Sato HK, Aguiar SG, Ribeiro JG, Soares RC, Codeco CT, , 2004. Risk of fatal adverse events associated with 17DD yellow fever vaccine. Epidemiol Infect 132: 939946.[Crossref] [Google Scholar]
  18. Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE, , 2007. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine 25: 27582765.[Crossref] [Google Scholar]
  19. Hayes EB, , 2007. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg 101: 967971.[Crossref] [Google Scholar]
  20. Whittembury A, Ramirez G, Hernandez H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martinez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes E, , 2009. Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27: 59745981.[Crossref] [Google Scholar]
  21. Hindle E, , 1930. The transmission of yellow fever. Lancet 219: 835842.[Crossref] [Google Scholar]
  22. Massad E, Coutinho FA, Burattini MN, Lopez LF, , 2001. The risk of yellow fever in a dengue-infested area. Trans R Soc Trop Med Hyg 95: 370374.[Crossref] [Google Scholar]
  23. Monath TP, Barrett AD, , 2003. Pathogenesis and pathophysiology of yellow fever. Adv Virus Res 60: 343395.[Crossref] [Google Scholar]
  24. Codeco CT, Luz PM, Coelho F, Galvani AP, Struchiner C, , 2007. Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface 4: 11191125.[Crossref] [Google Scholar]
  25. Davis N, , 1932. The effect of various temperatures in modifying the extrinsic incubation period of the yellow fever virus in Aedes aegypti . Am J Epidemiol 16: 163176.[Crossref] [Google Scholar]
  26. Watts DM, Burke DS, Harrison BA, Whitmire RE, Nisalak A, , 1987. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg 36: 143152. [Google Scholar]
  27. New M, Lister D, Hulme M, Makin I, , 2002. A high-resolution data set of surface climate over global land areas. Clim Res 21: 125.[Crossref] [Google Scholar]
  28. Bates M, Roca-Garcia M, , 1946. The development of the virus of yellow fever in Haemagogus mosquitoes. Am J Trop Med Hyg 26: 585605. [Google Scholar]
  29. Lunn DJ, Thomas A, Best N, Spiegelhalter D, , 2000. WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 10: 325337.[Crossref] [Google Scholar]
  30. Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A, , 2002. Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodol 64: 583616.[Crossref] [Google Scholar]
  31. Reed W, Carroll J, Agramonte A, Lazear JW, , 1900. The etiology of yellow fever—a preliminary note. Public Health Pap Rep 26: 3753. [Google Scholar]
  32. Reed W, Carroll J, Agramonte A, , 1901. The etiology of yellow fever-an additional note. J Am Med Assoc 36: 431440.[Crossref] [Google Scholar]
  33. Reed W, Carroll J, Carroll J, Gorgas W, Owen R, McCaw W, , 1911. The etiology of yellow fever-a supplemental note. , eds. Yellow Fever: A Compilation of Various Publications. Washington, DC: Government Printing Office, 149160. [Google Scholar]
  34. Guiteras J, , 1901. Experimental yellow fever at the inoculation station of the sanitary department of Havana with a view to producing immunization. American Medicine 21: 809817. [Google Scholar]
  35. Marchoux E, Salimbeni A, Simond P, , 1903. La fièvre jaune: rapport de la mission française. Ann Inst Pasteur (Paris) 17: 665731. [Google Scholar]
  36. Rosenau M, Parker H, Francis E, Beyer G, , 1904. Experimental Studies in Yellow Fever and Malaria at Vera Cruz, Mexico. Washington, DC: Government Printing Office. [Google Scholar]
  37. Parker H, Beyer G, Pothier O, , 1903. A Study of the Etiology of Yellow Fever. Washington, DC: Government Printing Office. [Google Scholar]
  38. Bauer J, Hudson N, , 1928. The incubation period of yellow fever in the mosquito. J Exp Med 48: 147153.[Crossref] [Google Scholar]
  39. Stokes A, Bauer J, Hudson N, , 1928. Experimental transmission of yellow fever to laboratory animals. Am J Trop Med Hyg 8: 103164. [Google Scholar]
  40. Hindle E, , 1929. An experimental study of yellow fever. Trans R Soc Trop Med Hyg 22: 405430.[Crossref] [Google Scholar]
  41. Carter H, , 1900. A note on the interval between infecting and secondary cases of yellow fever from the records of the yellow fever at Orwood and Taylor, Mississippi in 1898. New Orleans Med Surg J 52: 617636. [Google Scholar]
  42. Carter H, , 1901. The period of incubation of yellow fever: a study from unpublished observations. Med Rec 59: 361367. [Google Scholar]
  43. Carter H, , 1901. A note on the spread of yellow fever in houses: extrinsic incubation. Med Rec 59: 933937. [Google Scholar]
  44. Beeuwkes H, , 1936. Clinical manifestations of yellow fever in the West African native as observed during four extensive epidemics of the disease in the Gold Coast and Nigeria. Trans R Soc Trop Med Hyg 30: 6186.[Crossref] [Google Scholar]
  45. Reisen WK, Fang Y, Martinez VM, , 2006. Effects of temperature on the transmission of West Nile virus by Culex tarsalis (Diptera: Culicidae). J Med Entomol 43: 309317. [Google Scholar]
  46. Richards SL, Lord CC, Pesko K, Tabachnick WJ, , 2009. Environmental and biological factors influencing Culex pipiens quinquefasciatus say (Diptera: Culicidae). Am J Trop Med Hyg 81: 264272. [Google Scholar]
  47. Styer LM, Minnick SL, Sun AK, Scott TW, , 2007. Mortality and reproductive dynamics of Aedes aegypti (Diptera: Culicidae) fed human blood. Vector Borne Zoonotic Dis 7: 8698.[Crossref] [Google Scholar]
  48. Christophers SR, , 1960. Aedes aegypti (L.): The Yellow Fever Mosquito. Cambridge, England: The University Press. [Google Scholar]
  49. Monath TP, Nasidi A, , 1993. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg 48: 274299. [Google Scholar]
  50. Massad E, Coutinho FA, Burattini MN, Lopez LF, Struchiner CJ, , 2005. Yellow fever vaccination: how much is enough? Vaccine 23: 39083914. [Google Scholar]
  51. Wearing HJ, Rohani P, Keeling MJ, , 2005. Appropriate models for the management of infectious diseases. PLoS Med 2: 621627. [Google Scholar]
  52. American Academy of Pediatrics Pickering L, Baker C, Kimberlin D, Long S, , 2009. Hepatitis A, B, C, and D. , eds. Red Book: 2009 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0782
Loading
/content/journals/10.4269/ajtmh.2010.09-0782
Loading

Data & Media loading...

  • Received : 23 Dec 2009
  • Accepted : 08 Apr 2010
  • Published online : 06 Jul 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error